With Entry of SGLT-2 Inhibitors, Competition Heating Up Again in Oral Anti-Diabetes Drug Market

Competition in the oral anti-diabetic drug market is heating up. In the first quarter of FY2014 (April-June), sodium-glucose co-transporter-2 (SGLT-2) inhibitors made their debut, while changes began to appear in the competitive landscape among dipeptidyl peptidase-4 (DPP-4) inhibitors. Let’s look...read more